In public health, progress is often measured not just by ambition, but by outcomes. Few countries today illustrate this more clearly than Sweden – a Nation that is quietly redefining what success in tobacco control can look like.
With adult smoking rates now at approximately 5.6 per cent, Sweden stands on the threshold of becoming Europe’s first smoke-free society. This is not simply a statistical milestone; it represents a profound shift in how nicotine consumption is understood and managed at a population level. While much of the world continues to frame tobacco control in binary terms (use versus abstinence), Sweden’s experience highlights a more nuanced reality: the greatest gains often come not just from eliminating risk, but from reducing it.
At the heart of this transformation lies the concept of tobacco harm reduction. The principle is straightforward but powerful. There is a distinct difference between Tobacco and not all nicotine-delivery products carry the same level of risk. Combustible cigarettes, which involve burning tobacco and inhaling smoke, remain the most direct and traditional form of nicotine consumption. By contrast, non-combustible alternatives, such as smokeless oral products and modern nicotine delivery systems, significantly reduce exposure to the toxic byproducts of combustion of tobacco.
Sweden’s public health gains are closely tied to this distinction. Over time, a substantial number of nicotine users in the country have moved away from cigarettes toward reduced-risk alternatives, particularly snus, a traditional smokeless tobacco product. This behavioural shift has not eliminated nicotine use, but it has dramatically reduced the health burden associated with more traditional cigarette smoking.
The results are measurable. Sweden records not only the lowest smoking prevalence in Europe but also among the lowest incidences of smoking-related illnesses, including lung cancer. This is a critical point: the harm reduction is not theoretical; it is reflected in real-world health outcomes.
What makes this especially significant is that it challenges a long-standing assumption in global health discourse: that meaningful progress can only come from complete cessation. While quitting all tobacco and nicotine use remains the ideal, Sweden’s experience demonstrates that substantial public health gains can also be achieved when adult smokers transition to reduced-risk alternatives.
This is where tobacco harm reduction offers its greatest value, not as a replacement for prevention or cessation, but as a complementary pathway.
It acknowledges a fundamental reality of human behaviour: many individuals who smoke do not quit immediately or entirely.
Providing lower-risk options creates an alternative trajectory, one that can lead to reduced exposure, improved health outcomes, and, over time, potentially complete cessation.
Beyond individual health, broader societal implications are equally important. Lower rates of smoking-related illness translate into reduced healthcare burdens, improved productivity, and longer life expectancy. These are not marginal benefits; they are systemic gains that affect entire populations.
Importantly, the Swedish experience also underscores the role of informed choice. When individuals understand the relative risks of different nicotine products, many make decisions that favour lower-risk options. This is not about promoting use but about enabling better outcomes within existing patterns of behaviour.
Globally, the conversation around tobacco use is gradually evolving. Increasingly, attention is shifting toward risk differentiation. Recognising that treating all nicotine-delivery products as equally harmful may overlook opportunities to reduce disease and save lives. Sweden’s trajectory provides a compelling case study in how this perspective can translate into tangible results.
While the World Health Organisation, in its recent report[WT1] , maintains that all tobacco and nicotine products, including vapes, heated tobacco products, and nicotine pouches, carry health risks and should not be regarded as risk-free alternatives, there is a growing case for the organization to re-examine its position in light of emerging scientific evidence. A more nuanced, evidence-based approach that acknowledges the continuum of risk across nicotine products could better support global tobacco harm reduction efforts and provide adult smokers with access to potentially less harmful alternatives.
For countries at earlier stages of this journey, the lesson is not about replication but about understanding. Sweden’s success is rooted in a pragmatic alignment among science, behaviour, and public health objectives. It reflects a willingness to engage with the complex dynamics at play rather than trying to reduce it to a simple “Quit or Die” approach.
Ultimately, tobacco harm reduction refrains from the goal of tobacco control. Instead of focusing solely on eliminating use, it expands the objective to include reducing harm wherever possible. In doing so, it offers a more flexible and arguably more effective pathway toward improved public health.
Sweden’s story is not just about being smoke-free. It is about what becomes possible when public health strategies evolve to meet people where they are, and guide them, step by step, toward lower-risk outcomes.
Godswill I boma is a public health advocate and a consultant with the Lagos State Ministry of Health
[WT1]Citation, including date and year, to be inserted.
